Full text

Turn on search term navigation

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

(1) The Russian invasion of Ukraine forced many people to leave their country and seek asylum in various European countries, with serious consequences from a health perspective. In this context, we describe the health measures undertaken by AcToVax4NAM Consortium Countries (Cyprus–Germany–Greece–Italy–Malta–Poland–Romania–Spain) to prevent Vaccine-Preventable Disease (VPD) outbreaks in the context of mass movements of populations that resulted from the crisis in Ukraine. (2) We collected information on the vaccinations offered to Ukrainians in the Consortium Countries. (3) All these countries have provided Temporary Protection (TP) status to refugees from Ukraine and have followed the recommendations of European and International Agencies to offer them vaccinations according to the National Immunisation Programmes. The COVID-19 vaccination is offered in all countries with regard to the general population. Most countries provide information on TP and access to health/vaccination services in the Ukrainian language. (4) The information collected shows a common effort to ensure the adequate planning of health and vaccination services for refugees from Ukraine and, very often, to include them in the national vaccination offer. It is important that this initial response towards people who have fled Ukraine will be continued following the emergency but, more importantly, that it serves as a best practice towards all migrants and refugees entering the EU.

Details

Title
The Opportunity Provided by Vaccination Offer to Refugees from Ukraine in European Countries
Author
Marchetti, Giulia 1   VIAFID ORCID Logo  ; Franca D’Angelo 1 ; Ferrari, Caterina 2 ; Bellini, Arianna 2   VIAFID ORCID Logo  ; Sabato, Marise 2   VIAFID ORCID Logo  ; Scarso, Salvatore 3   VIAFID ORCID Logo  ; Karnaki, Pania 4 ; Marceca, Maurizio 2   VIAFID ORCID Logo  ; Russo, Maria Laura 2 ; Tosti, Maria Elena 1   VIAFID ORCID Logo  ; Declich, Silvia 1 

 National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy; [email protected] (F.D.); [email protected] (S.S.); [email protected] (M.E.T.); [email protected] (S.D.) 
 Department of Public Health and Infectious Diseases, Sapienza Università di Roma, 00185 Rome, Italy; [email protected] (C.F.); [email protected] (A.B.); [email protected] (M.S.); [email protected] (M.M.); [email protected] (M.L.R.) 
 National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy; [email protected] (F.D.); [email protected] (S.S.); [email protected] (M.E.T.); [email protected] (S.D.); Department of Public Health and Infectious Diseases, Sapienza Università di Roma, 00185 Rome, Italy; [email protected] (C.F.); [email protected] (A.B.); [email protected] (M.S.); [email protected] (M.M.); [email protected] (M.L.R.) 
 Prolepsis Institute, 151 25 Athens, Greece; [email protected] 
First page
589
Publication year
2024
Publication date
2024
Publisher
MDPI AG
e-ISSN
2076393X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3072696902
Copyright
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.